---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-079606"
form_type: "8-K"
ticker: "OMCL"
cik: "0000926326"
company_name: "OMNICELL, INC."
filed_at: "2026-07-01T12:27:47+00:00"
generated_at: "2026-07-01T12:30:08.492467+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Omnicell appoints Nnamdi Njoku as President; Lipps remains CEO and Chairman

## Summary
- Nnamdi Njoku appointed President of Omnicell effective July 1, 2026, while retaining COO role.
- Randall Lipps steps down as President but continues as CEO and Chairman of the Board; no compensation change.
- Njoku receives one-time RSU award of ~$500k vesting over three years; base salary unchanged at $661k, target bonus 100%.
- Njoku to lead growth strategy, launch of Titan XT automated dispensing system and OmniSphere platform.
- Njoku previously served as EVP and COO since Oct 2024; prior roles at Medtronic, Zimmer Biomet.

## SEC filing metadata
- accession: 0001104659-26-079606
- form_type: 8-K
- ticker: OMCL
- cik: 0000926326
- company_name: OMNICELL, INC.
- filed_at: 2026-07-01T12:27:47+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926326/000110465926079606/0001104659-26-079606-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926326/000110465926079606/tm2619353d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-079606
- JSON: https://secwatch.observer/filing/0001104659-26-079606.json
- Plain text: https://secwatch.observer/filing/0001104659-26-079606.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.